Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants

被引：0
|
作者：
Steven J. Smith
Gary T. Pauly
Aamir Akram
Kevin Melody
Ganesha Rai
David J. Maloney
Zandrea Ambrose
Craig J. Thomas
Joel T. Schneider
Stephen H. Hughes
机构：
[1] National Institutes of Health,HIV Drug Resistance Program, National Cancer Institute
[2] National Institutes of Health,Frederick
[3] University of Pittsburgh,Chemical Biology Laboratory, National Cancer Institute
[4] University of Pittsburgh,Frederick
[5] NIH,Department of Infectious Diseases and Microbiology, Graduate School of Public Health
来源：
Retrovirology | / 13卷
关键词：
HIV-1; Nonnucleoside reverse transcriptase inhibitors; Rilpivirine; Antiviral activity; Resistance; Analogs; Susceptibility; Binding pocket; Doravirine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants
    Smith, Steven J.
    Pauly, Gary T.
    Akram, Aamir
    Melody, Kevin
    Rai, Ganesha
    Maloney, David J.
    Ambrose, Zandrea
    Thomas, Craig J.
    Schneider, Joel T.
    Hughes, Stephen H.
    RETROVIROLOGY, 2016, 13
  • [2] N-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants
    Mahajan, Pankaj S.
    Smith, Steven J.
    Li, Min
    Craigie, Robert
    Hughes, Stephen H.
    Zhao, Xue Zhi
    Burke Jr, Terrence R.
    ACS INFECTIOUS DISEASES, 2024, 10 (03): : 917 - 927
  • [3] HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [4] Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    RETROVIROLOGY, 2018, 15
  • [5] Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
    Steven J. Smith
    Xue Zhi Zhao
    Terrence R. Burke
    Stephen H. Hughes
    Retrovirology, 15
  • [6] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [7] Drug-resistant genotyping in HIV-1 therapy
    Zöllner, B
    Feucht, HH
    Weitner, L
    Adam, A
    Laufs, R
    LANCET, 1999, 354 (9184): : 1120 - 1121
  • [8] Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions
    Martinez-Picado, J
    Morales-Lopetegi, K
    Wrin, T
    Prado, JG
    Frost, SDW
    Petropoulos, CJ
    Clotet, B
    Ruiz, L
    AIDS, 2002, 16 (06) : 895 - 899
  • [9] Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters
    Shen, Chen-Hsiang
    Wang, Yuan-Fang
    Kovalevsky, Andrey Y.
    Harrison, Robert W.
    Weber, Irene T.
    FEBS JOURNAL, 2010, 277 (18) : 3699 - 3714
  • [10] Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants
    Dykes, C
    Fox, K
    Lloyd, A
    Chiulli, M
    Morse, E
    Demeter, LM
    VIROLOGY, 2001, 285 (02) : 193 - 203
12345